BioSpace News Archive

Independent study validates CL-7 technology as a more efficient way to purify crucial proteins.

Todd Morgan, the former Chairman of the Board of Directors (the “Board”) of ProLung, Inc. (“ProLung” or, the “Company”), together with a group of shareholders collectively owning approximately 16.3% of the outstanding common stock of ProLung (the “Group”) and led by ProLung’s former President, CEO and director Steven Eror, delivered an encouraging message to ProLung shareholders today regarding the Group’s consent solicitation

FastMed, one of the nation’s largest urgent care providers in the U.S., announced today that it has launched a new service - baseline concussion testing - across all its Phoenix-area clinics.

SCOR Global Life continues to promote health and wellness initiatives through a new partnership with Human Longevity, Inc. (HLI), an innovator in providing data-driven health intelligence to a broader range of consumers.

Medline today announced an expanded distribution partnership with BioDerm®, Inc. that provides the company with exclusive rights to three additional products under BioDerm’s portfolio of urinary management, securement, and skin protection devices.

It’s Wednesday night, and retired Army Command Sgt. Maj. Christopher Greca has two feet up, watching Tom Hank’s most recent film to hit premium cable.

Kaiser Permanente will expand its number of medical centers to 30 by adding 5 new medical centers over the next 18 months, further expanding patients’ access to their choice of world-class providers in state-of-the-art facilities.

The kids are back to school, and now it’s time to get Back to YOU! That’s why Healthy For Life Meals is opening all 24 of its locations to anyone interested in learning more about its healthy, flexible meal service for its first-ever “Back to YOU” Event on September 6.

Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market, today announced that the Company will participate in the H.C. Wainwright 20th Annual Global Investment Conference, which takes place September 4-6, in New York.

Evofem Biosciences, Inc., (NASDAQ: EVFM) (“Evofem” or the “Company”), a clinical-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women’s sexual and reproductive health, believes that new data recently released by the Centers for Disease Control and Prevention (CDC) on the increasing rates of sexually transmitted diseases (